THOMSON TODD S — SEC insider filings
SEC reporting owner CIK 1225707. 6 insider filings on record with FilingPulse; latest filed 2026-11-02.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2021-01-06 to 2026-11-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 298,750 shares, $1,774,000 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 28.
- Largest priced transaction: sale of 280,000 shares @ $5.80 ($1,624,000) in ACTUATE THERAPEUTICS, INC., filed 2026-01-07.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ACTUATE THERAPEUTICS, INC. (ACTU) | Director | 5 | — | 2 legs · 298,750 sh · $1,774,000 | 27 |
| CYREN Ltd. (CYRN) | Director | 1 | — | — | 1 |
Insider filings — THOMSON TODD S
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-02 | 4 | ACTUATE THERAPEUTICS, INC. (ACTU) jointly with Kairos Venture Partners II, L.P., Kairos Venture Opportunities I, L.P., Kairos SPV Fund LLC, Kairos-Actuate SPV, L.P., Kairos Venture Investments, LLC, DEMETRIADES JAMES T | Grant/award (A): 269,017 (derivative) · Grant/award (A): 259,572 (derivative) · Grant/award (A): 75,738 (derivative) · Grant/award (A): 95,673 (derivative) | EDGAR |
| 2026-05-22 | 4 | ACTUATE THERAPEUTICS, INC. (ACTU) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2026-01-07 | 4 | ACTUATE THERAPEUTICS, INC. (ACTU) jointly with Kairos Venture Partners II, L.P. | Sale (S): 280,000 @ $5.80 | EDGAR |
| 2025-05-23 | 4 | ACTUATE THERAPEUTICS, INC. (ACTU) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2024-08-16 | 4 | ACTUATE THERAPEUTICS, INC. (ACTU) jointly with Kairos SPV Fund LLC, Kairos Venture Opportunities I, L.P., Kairos Venture Partners II, L.P., Kairos-Actuate SPV, L.P. | Conversion (C): 1,058,318 · Conversion (C): 726,163 · Conversion (C): 69,445 · Conversion (C): 146,870 · Conversion (C): 138,889 · Conversion (C): 230,597 · +16 more | EDGAR |
| 2021-01-06 | 4 | CYREN Ltd. (CYRN) | Grant/award (A): 20,000 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-01-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1225707 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs